α-fetoprotein, des-γ carboxyprothrombin, and lectin-bound α-fetoprotein in early hepatocellular carcinoma JA Marrero, Z Feng, Y Wang, MH Nguyen, AS Befeler, LR Roberts, ... Gastroenterology 137 (1), 110-118, 2009 | 853 | 2009 |
High‐dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis KD Lindor, KV Kowdley, VAC Luketic, ME Harrison, T McCashland, ... Hepatology 50 (3), 808-814, 2009 | 828 | 2009 |
Hepatocellular carcinoma: diagnosis and treatment AS Befeler, AM Di Bisceglie Gastroenterology 122 (6), 1609-1619, 2002 | 783 | 2002 |
Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study MP Curry, X Forns, RT Chung, NA Terrault, R Brown Jr, JM Fenkel, ... Gastroenterology 148 (1), 100-107. e1, 2015 | 382 | 2015 |
Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1 TD Boyer, AJ Sanyal, F Wong, RT Frederick, JR Lake, JG O’Leary, ... Gastroenterology 150 (7), 1579-1589. e2, 2016 | 306 | 2016 |
The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome AS Befeler, DE Palmer, M Hoffman, W Longo, H Solomon, ... Archives of Surgery 140 (7), 650-654, 2005 | 297 | 2005 |
High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis JE Eaton, MG Silveira, DS Pardi, E Sinakos, KV Kowdley, VAC Luketic, ... Official journal of the American College of Gastroenterology| ACG 106 (9 …, 2011 | 295 | 2011 |
Hepatitis C–related hepatocellular carcinoma in the United States: influence of ethnic status AM Di Bisceglie, AC Lyra, M Schwartz, RK Reddy, P Martin, G Gores, ... Official journal of the American College of Gastroenterology| ACG 98 (9 …, 2003 | 233 | 2003 |
GALAD score for hepatocellular carcinoma detection in comparison with liver ultrasound and proposal of GALADUS score JD Yang, BD Addissie, KC Mara, WS Harmsen, J Dai, N Zhang, ... Cancer Epidemiology, Biomarkers & Prevention 28 (3), 531-538, 2019 | 172 | 2019 |
Bile acid changes after high‐dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression E Sinakos, HU Marschall, KV Kowdley, A Befeler, J Keach, K Lindor Hepatology 52 (1), 197-203, 2010 | 133 | 2010 |
Liver transplantation for hepatocellular carcinoma AS Befeler, PH Hayashi, AM Di Bisceglie Gastroenterology 128 (6), 1752-1764, 2005 | 130 | 2005 |
Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection HH Diwakaran, AS Befeler, RS Britton, EM Brunt, BR Bacon Journal of hepatology 36 (5), 687-691, 2002 | 110 | 2002 |
Clinical course and management of inflammatory bowel disease after liver transplantation AS Befeler, TW Lissoos, TD Schiano, H Conjeevaram, KA Dasgupta, ... Transplantation 65 (3), 393-396, 1998 | 108 | 1998 |
Pretransplant Sofosbuvir and Ribavirin to Prevent Recurrence of HCV Infection after Liver Transplantation: 213 MP Curry, X Forns, RT Chung, N Terrault, RS Brown, JM Fenkel, ... Hepatology 58, 314A-315A, 2013 | 102 | 2013 |
High‐dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis MH Imam, E Sinakos, AA Gossard, KV Kowdley, VAC Luketic, ... Alimentary pharmacology & therapeutics 34 (10), 1185-1192, 2011 | 100 | 2011 |
Rapidly progressive liver injury and fatal alcoholic hepatitis occurring after liver transplantation in alcoholic patients HS Conjeevaram, J Hart, TW Lissoos, TD Schiano, K Dasgupta, ... Transplantation 67 (12), 1562-1568, 1999 | 89 | 1999 |
Improved performance of serum alpha-fetoprotein for hepatocellular carcinoma diagnosis in HCV cirrhosis with normal alanine transaminase JD Yang, J Dai, AG Singal, P Gopal, BD Addissie, MH Nguyen, AS Befeler, ... Cancer Epidemiology, Biomarkers & Prevention 26 (7), 1085-1092, 2017 | 57 | 2017 |
Potentially curative treatment in patients with hepatocellular cancer—results from the liver cancer research network F Kanwal, A Befeler, RS Chari, J Marrero, J Kahn, N Afdhal, T Morgan, ... Alimentary pharmacology & therapeutics 36 (3), 257-265, 2012 | 48 | 2012 |
hepatocellular carcinoma with bone metastases: incidence, prognostic significance, and management—single-center experience R Bhatia, S Ravulapati, A Befeler, J Dombrowski, S Gadani, N Poddar Journal of Gastrointestinal Cancer 48, 321-325, 2017 | 43 | 2017 |
Formation of downhill esophageal varices as a rare but serious complication of hemodialysis access: a case report and comprehensive literature review FA Hussein, N Mawla, AS Befeler, KJ Martin, KL Lentine Clinical and experimental nephrology 12, 407-415, 2008 | 36 | 2008 |